EL
Elanco
ELAN·NYSEGreenfield INFounded 201810,000 employees
Mid CappharmaPublicOncology
Platform: Animal Health
Market Cap
$8B
All Drugs
4
Clinical Trials
7
Failed / Terminated
3
FDA Approved
1
Stock Price & Catalysts (ELAN)
Loading ELAN stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ELA-1012 | ELA-1012 | NDA/BLA | 2 | KRASG12D | NMOSDHeart Failure | ||
| Capifotisoran | ELA-3933 | Approved | 2 | TIGIT | Bladder CaCTCL | ||
| Ivosotorasib | ELA-7062 | Phase 2/3 | 1 | EZH2 | LNSCD | ||
| ELA-3520 | ELA-3520 | Phase 2 | 2 | CD19 | SCDALS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (6)